Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $50.80 (+49.4%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/27/2013 Piper Jaffray Upgrade Neutral
(Underweight)
N/A
(N/A)
38.14 34.01 -10.83% Details
10/4/2013 JPMorgan New Coverage Neutral
(N/A)
37.00
(N/A)
35.83 34.01 -5.08% Details
Like ISIS Ratings? Also take a look at SNY, SAN, AZN, GSK

ISIS Ratings News